Specificity of doxorubicin versus rhodamine-123 in assessing P-glycoprotein functionality in the LLC-PK1, LLC-PK1:MDR1 and Caco-2 cell lines - Concepedia

Concepedia

Publication | Closed Access

Specificity of doxorubicin versus rhodamine-123 in assessing P-glycoprotein functionality in the LLC-PK1, LLC-PK1:MDR1 and Caco-2 cell lines

112

Citations

21

References

2000

Year

Inez C. J. van der Sandt, Margret C.M. Blom-Roosemalen, Albertus G. de Boer, D. D. Breimer

European Journal of Pharmaceutical Sciences

GlycosylationBiochemistryOncogenic AgentCaco-2 Cell LinesAnti-cancer AgentP-glycoprotein FunctionalityPharmacologyDoxorubicin Versus Rhodamine-123Drug Resistance

References

	Year	Citations

Page 1